Trials / Terminated
TerminatedNCT01949740
Patient Preferences in Making Treatment Decisions in Patients With Stage I-IVA Oropharyngeal Cancer
Patient Preferences in Head and Neck Cancer Treatment Decisions - a Pilot Study of the Durability of Patient Priorities
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 37 (actual)
- Sponsor
- University of Chicago · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This pilot research trial studies patient preferences in making treatment decisions in patients with stage I-IVA oropharyngeal cancer. Questionnaires that measure patient priorities before and after treatment may improve the ability to plan for better quality of life in patients with oropharyngeal cancer.
Detailed description
PRIMARY OBJECTIVES: I. Determine the stability of Head and Neck Priorities Scale (HNPS) ranking between pre- and post-treatment assessments. SECONDARY OBJECTIVES: I. Use patient-interviews to refine and modify the HNPS for use in a larger scale trial. II. Pilot the Head and Neck Patient Outcomes Survey (HNPOS) as a potential tool to identify priorities most important to quality-of-life outcomes. III. Use the Functional Assessment of Cancer Therapy - Head and Neck (FACT-H\&N) and EurolQoL-5D to determine the validity of the HNPOS. OUTLINE: Patients participate in a 45-minute interview comprising assessment of priorities and quality of life at baseline, 1, 6, and 12 months.
Conditions
- Stage I Squamous Cell Carcinoma of the Oropharynx
- Stage II Squamous Cell Carcinoma of the Oropharynx
- Stage III Squamous Cell Carcinoma of the Oropharynx
- Stage IVA Squamous Cell Carcinoma of the Oropharynx
- Tongue Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | questionnaire administration | Ancillary studies |
| PROCEDURE | quality-of-life assessment | Ancillary studies |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2013-09-24
- Last updated
- 2015-09-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01949740. Inclusion in this directory is not an endorsement.